In liver cancer, Erianin induces ferroptosis by activating JAK2/STAT3 and inhibiting SLC7A11 and GPX4 expression, reducing HCC cell proliferation and invasion (76). Here, SLC7A11 is linked to hepatocellular carcinoma.